Carestream Health Introduces New Mobile X-Ray Device

Article

The DRX-Rise Mobile X-ray System reportedly combines optimal image quality with enhanced maneuverability and ease of use for radiologists.

With the promise of artificial intelligence (AI)-powered image processing and features that promote workflow productivity and maneuverability, Carestream Health has launched the DRX-Rise Mobile X-ray System.

One of the features of the DRX-Rise Mobile X-ray System is Carestream Health’s AI-propelled ImageView Software, which facilitates image quality and dosing efficiency through robust image processing, according to Carestream Health.

The company said other attributes of the new X-ray system include in-bin detector charging, two touchscreen displays and new drive capabilities that help ensure optimal maneuverability and positioning at a patient’s bedside.

“The DRX-Rise Mobile X-ray System delivers high-end features that support the most critical needs in medical imaging: exceptional image quality for confident diagnosis; workflow-accelerating attributes for productivity; and a more comfortable imaging experience for patients – all without significantly impacting capital budget,” noted Jordan Berry, the global marketing manager for Carestream Health.

(Editor’s note: For related content, see “Autonomous AI Shows Nearly 27 Percent Higher Sensitivity than Radiology Reports for Abnormal Chest X-Rays” and “Canon Medical Launches New CT and X-Ray Modalities at ECR 2023.”)

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
Emerging Concepts in CT-Guided Treatment of Coronary Artery Disease
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.